Global Pharmaceutical Company Cinfa Hosts Spanish Prince and Princess at its State-of-the-Art Manufacturing Facilities
The UAE’s newest provider of European-standard medicines, Cinfa, has had one of its world-class Spanish manufacturing facilities endorsed with a high-level visit from the country’s royal family.
Accompanied by government officials and dignitaries, the Prince and Princess of Asturias took time last week to view the state-of-the-art facilities at the Cinfa headquarters, located in Navarre, Spain.
Cinfa is currently engaged in a regional expansion programme, with its entrance into the GCC region having taken place in April of this year, during which Enrique Ordieres, President of Cinfa, met with theSpanish Ambassador to the UAE, His Excellency Eugenio Salarich, along with senior health officials and preeminent healthcare professionals.
His Excellency Eugenio Salarich said they were proud to have Cinfa act as an ambassador for Spanish business through its recent expansion into the region via UAE.
Cinfa is bringing world-class levels of drug manufacturing to the GCC region at a time when demand for greater choice in pharmaceutical products in increasing. The need for a greater volume and choice of medications in the UAE is also being fuelled by the increasing prevalence of non-communicable diseases across the region, with conditions such as obesity, hypertension, and type-2 diabetes registering an all-time high. The World Health Organization’s figures show that a third of adults in the country are obese, with one out of five living with diabetes.
“Cinfa’s extensive drug portfolio comprises more than 120 active ingredients and 336 presentations, covering more than 35 major therapeutical areas and conditions, including hypertension and diabetes,” said Khalid Amin, Regional Director of Cinfa in the UAE. “We now have products in the market to address the need for more quality choice in medicine in the UAE, and we are using the country as our springboard for growth into other regional markets in the future,” he added.
Last year Cinfa recorded sales of nearly USD 430 million – a figure that showed an eight per cent year-on-year over 2011. This year, the organisation is investing more than USD 23 million in research, development and innovation. For the next three years, the planned investment is nearly USD 86 million – an increase of 60 per cent compared to the last three years.